These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4521093)

  • 21. Dissolution and relative bioavailability of two carbamazepine preparations for children with epilepsy.
    Hartley R; Aleksandrowicz J; Bowmer CJ; Cawood A; Forsythe WI
    J Pharm Pharmacol; 1991 Feb; 43(2):117-9. PubMed ID: 1672895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dose increments on serum carbamazepine concentration in epileptic patients.
    Perucca E; Bittencourt P; Richens A
    Clin Pharmacokinet; 1980; 5(6):576-82. PubMed ID: 7438655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Single evening administration of slow release carbamazepine].
    Stefan H; Schäfer H; Kuhnen C
    Nervenarzt; 1986 Jul; 57(7):405-7. PubMed ID: 3092119
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients.
    Patsalos PN
    Br J Clin Pharmacol; 1990 May; 29(5):574-7. PubMed ID: 2350535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism.
    Tomson T; Svensson JO; Hilton-Brown P
    Ther Drug Monit; 1989 Sep; 11(5):533-9. PubMed ID: 2815227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbamazepine serum levels in epileptics. Influence of age, sex, body weight and interaction with phenobarbital.
    De Michele G; Brescia Morra V; Pisanti N; Giani U; Filla A; Sinisi L; Capone D; Campanella G
    Acta Neurol (Napoli); 1985; 7(3-4):228-34. PubMed ID: 4061136
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum carbamazepine concentration--dose dependency and daily fluctuations.
    Takahashi Y; Nikkuni S; Honda K; Ono T; Kumashiro H
    Folia Psychiatr Neurol Jpn; 1980; 34(3):298. PubMed ID: 7216017
    [No Abstract]   [Full Text] [Related]  

  • 28. [Tegretol in the treatment of epilepsy].
    Salomez JL
    Lille Med; 1979 Dec; 24(10):812-3. PubMed ID: 119120
    [No Abstract]   [Full Text] [Related]  

  • 29. CSF concentrations and serum protein binding of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.
    Johannessen SI; Gerna M; Bakke J; Strandjord RE; Morselli PL
    Br J Clin Pharmacol; 1976 Aug; 3(4):575-82. PubMed ID: 22216497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preliminary report on the use of Tegretol sirup in epileptic patients].
    Monaco F; Riccio A; Furlan PM
    Riv Neurol; 1974 Mar; 44(2):123-33. PubMed ID: 4603758
    [No Abstract]   [Full Text] [Related]  

  • 31. [Carbamazepine dosage and its blood serum level in children].
    Czochańska J; Losiowski Z; Prokopczyk J; Zimak J
    Neurol Neurochir Pol; 1987; 21(1):6-10. PubMed ID: 3614524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary observations on the clinical pharmacology of carbamazepine ('Tegretol').
    Hooper WD; Dubetz DK; Eadie MJ; Tyrer JH
    Proc Aust Assoc Neurol; 1974; 11():189-98. PubMed ID: 4469631
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative drug monitoring of carbamazepin suspension (TroyaPharm) and Tegretol syrup (Ciba Geigy) in epileptic children.
    Peytchev L; Chakova L
    Folia Med (Plovdiv); 1998; 40(4):29-33. PubMed ID: 10371796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of josamycin on carbamazepine kinetics.
    Vinçon G; Albin H; Demotes-Mainard F; Guyot M; Bistue C; Loiseau P
    Eur J Clin Pharmacol; 1987; 32(3):321-3. PubMed ID: 3595706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of carbamazepine combinations in epilepsy.
    Cereghino JJ; Brock JT; Van Meter JC; Penry JK; Smith LD; White BG
    Clin Pharmacol Ther; 1975 Dec; 18(6):733-41. PubMed ID: 1106934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dosage frequency of carbamazepine on drug serum levels in epileptic patients.
    Ghose K; Fry DE; Christfides JA
    Eur J Clin Pharmacol; 1983; 24(3):375-81. PubMed ID: 6861851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epoxide of carbamazepine.
    McKauge L; Tyrer JH; Eadie MJ
    Clin Exp Neurol; 1979; 16():95-104. PubMed ID: 550961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative differences between protein in blood serum and in cerebrospinal fluid of psychotics the polarographic and electrophoretic studies.
    Ueno Y; Kuraishi F; Uematsu S; Tsuruoka T
    Folia Psychiatr Neurol Jpn; 1968; 22(2):167-84. PubMed ID: 5755137
    [No Abstract]   [Full Text] [Related]  

  • 40. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
    Furlanut M; Montanari G; Bonin P; Casara GL
    J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.